Schedule 13D ownership disclosure

Paratek Pharmaceuticals Inc

Security class unavailable · CUSIP: 699374302

Event date: 2023-03-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-23-007913
Form type
SC 13D
Filer
NexPoint Real Estate Opportunities, LLC
CIK
CIK 1957368
Filed
Mar 27, 2023
Reporting period
Mar 16, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub